Difference between revisions of "Part:BBa K3883031"

m (→‎Characterization)
m (→‎Usage and Biology)
Line 10: Line 10:
 
The introduction of mutations in the nuclease domain of Cas9 from Streptococcus pyogenes produces nuclease defects, turning Cas9 into dCas9 protein which is deficient in nucleic acid cutting activity. But it can still target and bind certain DNA with the same precision under the guidance of the corresponding RNA.
 
The introduction of mutations in the nuclease domain of Cas9 from Streptococcus pyogenes produces nuclease defects, turning Cas9 into dCas9 protein which is deficient in nucleic acid cutting activity. But it can still target and bind certain DNA with the same precision under the guidance of the corresponding RNA.
 
Artificial synthesis of sgRNA2(<partinfo>BBa_K3883005</partinfo>) includes a pairing region binding to gene gltA and a Cas9 handle region interacting with dCas9, so that dCas9-sgRNA2 complex can bind to target DNA elements and cause spatial block to prevent transcription extension of RNA polymerase, resulting in precise site-specific regulation of gene gltA without causing DNA damage.
 
Artificial synthesis of sgRNA2(<partinfo>BBa_K3883005</partinfo>) includes a pairing region binding to gene gltA and a Cas9 handle region interacting with dCas9, so that dCas9-sgRNA2 complex can bind to target DNA elements and cause spatial block to prevent transcription extension of RNA polymerase, resulting in precise site-specific regulation of gene gltA without causing DNA damage.
−
Citrate synthase is a key enzyme in the tricarboxylic acid cycle. Inhibition of GltA gene encoding this enzyme through this part can effectively inhibit the tricarboxylic acid cycle, thus reducing the metabolic shunt of acetyl-CoA and making acetyl-CoA flow to the pathway of acetic acid synthesis to the maximum extent.For more information, please visit our Design page:<partinfo> https://2021.igem.org/Team:Jilin_China/Design</partinfo>
+
Citrate synthase is a key enzyme in the tricarboxylic acid cycle. Inhibition of GltA gene encoding this enzyme through this part can effectively inhibit the tricarboxylic acid cycle, thus reducing the metabolic shunt of acetyl-CoA and making acetyl-CoA flow to the pathway of acetic acid synthesis to the maximum extent.For more information, please visit our Design page:https://2021.igem.org/Team:Jilin_China/Design
−
 
+
  
 
===Characterization===
 
===Characterization===

Revision as of 15:07, 20 October 2021

targeted knockdown the expression of gltA gene through CRISPRi

This part targeted knockdown the expression of gltA gene through CRISPRi to downregulate TCA cycle.By qRT-PCR, the inhibitory effect of CRISPRi system on gltA gene is verified.

Usage and Biology

Fig. 1 The pathway of pT7-dCas9-sgRNA.


The introduction of mutations in the nuclease domain of Cas9 from Streptococcus pyogenes produces nuclease defects, turning Cas9 into dCas9 protein which is deficient in nucleic acid cutting activity. But it can still target and bind certain DNA with the same precision under the guidance of the corresponding RNA. Artificial synthesis of sgRNA2(BBa_K3883005) includes a pairing region binding to gene gltA and a Cas9 handle region interacting with dCas9, so that dCas9-sgRNA2 complex can bind to target DNA elements and cause spatial block to prevent transcription extension of RNA polymerase, resulting in precise site-specific regulation of gene gltA without causing DNA damage. Citrate synthase is a key enzyme in the tricarboxylic acid cycle. Inhibition of GltA gene encoding this enzyme through this part can effectively inhibit the tricarboxylic acid cycle, thus reducing the metabolic shunt of acetyl-CoA and making acetyl-CoA flow to the pathway of acetic acid synthesis to the maximum extent.For more information, please visit our Design page:https://2021.igem.org/Team:Jilin_China/Design

Characterization

Characterizations of this part is in exactly the same way as BBa_K3883030.

Fig. 2 The sgRNA targeting PPCand gltA can reduce the corresponding mRNA level.(A) Primers designed for sgRNA-PPCand sgRNA-gltA. (B&C) Digestion and electrophoresis of two constructs. (D&E) The knockdown efficiency of sgRNA to PPC and gltA genes. The designed plasmid was transformed into E coli. BL21 and cultured until the value of OD600 reaches 0.4. After 8h IPTG induction, RNA extraction and reverse transcription were carried out. 16S rRNA was used as the reference gene and relative quantification was performed by qRT-PCR.



Sequence and Features


Assembly Compatibility:
  • 10
    COMPATIBLE WITH RFC[10]
  • 12
    INCOMPATIBLE WITH RFC[12]
    Illegal NheI site found at 1202
    Illegal NheI site found at 4217
    Illegal NheI site found at 4240
  • 21
    COMPATIBLE WITH RFC[21]
  • 23
    COMPATIBLE WITH RFC[23]
  • 25
    COMPATIBLE WITH RFC[25]
  • 1000
    INCOMPATIBLE WITH RFC[1000]
    Illegal BsaI.rc site found at 49